Techsol, a technology service provider for the pharmaceutical and life sciences industry, has released “QuickLaunch,” an accelerated Oracle Health Sciences' LabPas deployment package that enables pharmaceutical companies, CROs and academic medical research institutions to swiftly automate their current early phase clinical units in compliance with the FDA.

The company also has re-engineered a flexible “Early Phase Clinical Trials Process Management Framework” to augment the automation capabilities of LabPas, to make clinical unit operations more lean and efficient, reducing effort, time and cost for those conducting early-phase clinical trials.

 “We designed this package along with its deployment framework based on our industry insight and understanding of challenges faced by companies while setting up a regulatory-compliant, automated, early-phase clinical unit,” said Subbaraju Sagi, M.D., CEO of Techsol.

Techsol is affiliated with Oracle as a Gold Partner through the Oracle Partner Network (OPN).